Tianjin TEDA Biomedical Engineering Co Ltd - Class H

HKSE:08189 (China)   Class H
HK$ 0.27 (-3.57%) Nov 29
At Loss
P/B:
9.00
Market Cap:
HK$ 511.65M ($ 65.75M)
Enterprise V:
HK$ 610.76M ($ 78.48M)
Volume:
1.52M
Avg Vol (2M):
185.80K
Trade In:
Volume:
1.52M
At Loss
Avg Vol (2M):
185.80K

Business Description

Description
Tianjin TEDA Biomedical Engineering Co Ltd is engaged in the research, development, and commercialization of biological compound fertilizers, providing elderly and health care services. It operates in two segments namely; biological compound fertilizers products, and elderly care and health care services. The company generates a majority of its revenue from the Fertilisers products segment which is engaged in manufacturing and selling biological compound fertiliser products, including active fertiliser, mixture with nitrogen, phosphorus, and potassium with various formulas, providing warehousing services, and processing and licensing of the fertiliser products. The People's Republic of China is the primary geographical market for the company.
Name Current Vs Industry Vs History
Cash-To-Debt 0.17
Equity-to-Asset 0.15
Debt-to-Equity 2.41
Debt-to-EBITDA -15.47
Piotroski F-Score 6/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 0.01
Distress
Grey
Safe
Beneish M-Score -3.49
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 46.3
9-Day RSI 53.47
14-Day RSI 56.65
6-1 Month Momentum % 186.76
12-1 Month Momentum % 109.68

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 0.89
Quick Ratio 0.54
Cash Ratio 0.08
Days Inventory 85.99
Days Sales Outstanding 11.82
Days Payable 11.68

Dividend & Buy Back

Name Current Vs Industry Vs History
Shareholder Yield % 1.11

Financials

HKSE:08189's 30-Y Financials
Income Statement Breakdown FY
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Tianjin TEDA Biomedical Engineering Co Ltd Executives

Details

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil HK$) 436.717
EPS (TTM) (HK$) -0.012
Beta 0.13
Volatility % 162.09
14-Day RSI 56.65
14-Day ATR (HK$) 0.029459
20-Day SMA (HK$) 0.24765
12-1 Month Momentum % 109.68
52-Week Range (HK$) 0.065 - 0.4
Shares Outstanding (Mil) 1,895

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 6
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Tianjin TEDA Biomedical Engineering Co Ltd Filings

Filing Date Document Date Form
No Filing Data

Tianjin TEDA Biomedical Engineering Co Ltd Stock Events

Financials Calendars
Event Date Price(HK$)
No Event Data

Tianjin TEDA Biomedical Engineering Co Ltd Frequently Asked Questions

What is Tianjin TEDA Biomedical Engineering Co Ltd(HKSE:08189)'s stock price today?
The current price of HKSE:08189 is HK$0.27. The 52 week high of HKSE:08189 is HK$0.40 and 52 week low is HK$0.07.
When is next earnings date of Tianjin TEDA Biomedical Engineering Co Ltd(HKSE:08189)?
The next earnings date of Tianjin TEDA Biomedical Engineering Co Ltd(HKSE:08189) is .
Does Tianjin TEDA Biomedical Engineering Co Ltd(HKSE:08189) pay dividends? If so, how much?
Tianjin TEDA Biomedical Engineering Co Ltd(HKSE:08189) does not pay dividend.

Press Release

Subject Date
No Press Release